Sermorelin, GHRP-6, GHRP-2

The triple-peptide stack of Sermorelin, GHRP-6, and GHRP-2 combines all three complementary growth hormone pathways simultaneously—Sermorelin triggering production via GHRH, GHRP-6 amplifying release plus appetite and anti-inflammatory support, and GHRP-2 providing additional secretagogue power and muscle-structural enhancement. While individual addition doesn’t yield proportionally greater GH spikes than dual stacks, the combination provides multi-system benefits spanning muscle growth, fat loss, appetite support, inflammation reduction, cardiovascular protection, and metabolic optimization.

Route

Subcutaneous injection

Dose range

100 mcg – 600 mcg

Frequency

1–2 times per day

Cycle length

12–16 weeks

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

The triple-peptide stack of Sermorelin, GHRP-6, and GHRP-2 combines all three complementary growth hormone pathways simultaneously—Sermorelin triggering production via GHRH, GHRP-6 amplifying release plus appetite and anti-inflammatory support, and GHRP-2 providing additional secretagogue power and muscle-structural enhancement. While individual addition doesn’t yield proportionally greater GH spikes than dual stacks, the combination provides multi-system benefits spanning muscle growth, fat loss, appetite support, inflammation reduction, cardiovascular protection, and metabolic optimization.

Ideal for comprehensive GH optimization addressing all anabolic and metabolic needs simultaneously, this stack delivers complete growth hormone axis rejuvenation. The triple mechanism supports maximum pituitary responsiveness while providing diverse benefits beyond pure GH amplification. For elite athletes or serious therapeutic restoration seeking absolute maximum GH benefits and multi-system optimization, this combination represents the ultimate natural GH secretagogue stack.

Studied benefits

  • A "triple-pulse" secretagogue stack that maximizes the GH release through multiple signaling pathways
  • It offers a comprehensive approach to body recomposition, metabolic health, and tissue repair by ensuring a high-amplitude GH pulse

Reported side effects

  • Increased hunger is the most prominent side effect
  • Possible transient tingling in the hands (paresthesia) and standard injection-site redness may occur

Protocol

Dosing Schedule (Subcutaneous)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

PhaseTotal Dose (mcg)Draw at 2.5 mg/mLLog
Standard Research300 mcg (100mcg each)12 units (0.12 mL)+ Log
Advanced Pulse600 mcg (200mcg each)24 units (0.24 mL)+ Log

Frequency

1–2 times per day.

Timing

Administer on an empty stomach; bedtime or immediately upon waking is the research standard.

Cycle length

12–16 weeks.

Unit calculator

Set your vial and water; the table above updates.

Open the full calculator →
Concentration

2.5 mg/mL

16 doses of 300 mcg per vial

At the starting dose (300 mcg × 7/week for a 12-week cycle) you would use about 25.2 mg, i.e. 6 × 5 mg vials. Higher phases use proportionally more.

Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.

Context

Lifestyle considerations

This "triple secretagogue" protocol requires a high-protein, hypercaloric diet if the goal is significant mass gain, as the combined ghrelin-receptor activation will dramatically increase hunger. Follow a structured resistance training program to utilize the massive growth hormone spikes for tissue remodeling and hypertrophy. Ensure 7–9 hours of quality sleep to support the intense recovery and anabolic signaling initiated by the blend. Maintain strict fasting for 2 hours prior to administration and 30–60 minutes after to ensure that insulin spikes do not inhibit the signaling at the GHRH and GHRP receptors in the pituitary gland.

Evidence

Research summaries

Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels (GHRP-6/GHRP-2/SERM Triple Combination)

Findings: Massive increases in IGF-1 and testosterone, optimizes lean muscle and fat loss simultaneously, improves sexual function and energy in hypogonadal (low-testosterone) men, preserves normal hormonal feedback.

This landmark study followed 14 men with low testosterone who received the triple peptide blend: GHRP-6 (100 mcg), GHRP-2 (100 mcg), and sermorelin (100 mcg)—each injected three times daily. Over 134 days, their IGF-1 rocketed from 159.5 to 239.0 ng/mL, a 50% surge. But IGF-1 is just the marker; testosterone and free testosterone both increased significantly after 90 days of treatment. Crucially, luteinizing hormone (LH) and follicle-stimulating hormone (FSH)—your brain's signals to make testosterone—didn't change, meaning the peptides didn't suppress the pituitary's native testosterone axis. This preservation of natural feedback is a huge safety win versus exogenous testosterone. Men on estrogen-blocking drugs (aromatase inhibitors) still got IGF-1 boosts, proving the combination works through multiple pathways—not just the estrogen system. The researchers concluded this triple combo is "beneficial in wasting conditions" and for "men seeking gains in lean body mass and fat loss." Remarkably, strict three-times-daily compliance was essential; men refilling prescriptions within 45 days (showing adherence) saw benefits, while non-compliant men dropped out. This teaches us that pulsatile (frequent) dosing matters—you're coaching your body's natural GH release rhythm, not flooding it with constant hormone. No serious side effects occurred in the study.

Read the study ↗

The Safety and Efficacy of Growth Hormone Secretagogues (Comprehensive Review of GHRP-2, GHRP-6, and Sermorelin Combinations)

Findings: Increases growth velocity in children (5–8 cm/year sustained), restores growth hormone in critical illness, stimulates appetite in eating disorders (6+ kg weight gains), builds lean muscle in aging and wasting states, improves sleep quality.

This definitive review compiled clinical evidence on all GH secretagogues, highlighting that combinations outperform single drugs. When GHRP-2 and GHRP-6 are used together with sermorelin (a GHRH analog), the synergistic effect creates "the strongest growth hormone response" because they attack GH release via complementary pathways: sermorelin hits GHRH receptors; GHRP-2 and GHRP-6 hit ghrelin receptors. Neither blocks the other; instead, they amplify pituitary responsiveness. Key clinical results: six children treated with GHRP-2 (5–15 mcg/kg, twice or thrice daily) for 18–24 months sustained ~6.0 cm/year growth—stellar for short kids. In hospital patients with critical illness (surgery, trauma, polytrauma), GHRP-2 infusions normalized collapsed GH, IGF-1, IGF-binding proteins, and thyroid hormones—essentially rebooting the endocrine system. For adults: ibutamoren (an oral GHS) improved fat-free mass (+3 kg in 2 months) and reversed nitrogen wasting, while injectable GHRPs did similar. Sleep exploded with ibutamoren: 50% longer stage 4 (deep) sleep and >20% longer REM sleep in young men. The review emphasized: GHSs preserve negative feedback loops (somatostatin restraint), preventing dangerous GH overdose—a built-in safety feature. Side effects were mild: transient appetite increase, occasional cortisol spike (vanishes quickly), and in some, slight glucose elevation (monitored via HbA1c). The paucity of long-term data (>2 years) was the main limitation; the authors called for longer trials. For 9th graders: the triple combo is like having three different keys to unlock the same safe, each key working a different lock—opening it faster and safer than any single key.

Read the study ↗

Synthetic Growth Hormone-Releasing Peptides (GHRPs): Cardioprotection, Cytoprotection, and Synergistic Multi-Organ Effects

Findings: Protects heart from attack and failure, preserves brain and organ function during stress or injury, reduces inflammation and scar tissue throughout the body, improves

More references (5)

Identification

Chemistry

cas
158861-67-7
formula
C₁₄₉H₂₄₆N₄₄O₄₂S
molecular weight
3357.9–3357.93 g/mol (free base); 3417.99 g/mol (acetate salt with hydration)
sequence
-
biosynthesis
Synthetic (laboratory-synthesized)
type
Non-glycosylated synthetic polypeptide

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor